Comparison of single dose and s double dose of mifepristone followed by misoprostol for termination of pregnancy in second trimester

Phase 4

• Conditions: Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complicationsHealth Condition 2: O048- (Induced) termination of pregnancywith other and unspecified complications

• Registration Number: CTRI/2020/04/024862
• Lead Sponsor: OT APPLICABLE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

singleton intrauterine viable pregnancy

Gestational age 13-20 weeks

Women fulfilling the pre-requisites of Indian MTP Act, 1972

Exclusion Criteria

1.Prior two or more uterine surgeries (caesarean section or myomectomy)

2. Having either taken MTP Pill from outside or self prescribed

3. With inevitable or incomplete abortion

4. Moderate or severe anaemia (Haemoglobin <8 gm /dL)

5 .Heart disease, uncontrolled hypertension ( >140/90 mm Hg), diabetes mellitus, bronchial asthma, coagulation disorder and any other medical illness

6 .Known hypersensitivity to mifepristone or misoprostol

7.Haemodynamically unstable at the time of presentation

8.Contra-indications to mifepristone or misoprostol: ectopic pregnancy, inherited porphyria, chronic adrenal failure, on immunosuppressants (corticosteroids).

Study & Design

• Study Type: Interventional
• Study Design: Not specified